Healthcare -
Biotechnology - NASDAQ - US
$ 560.93
-7.47 %
$ 59.5 B
Market Cap
14.19
P/E
REGN - REVENUE
Revenue REGN - Regeneron Pharmaceuticals, Inc.
14.2 B
LAST VALUE
8.01%
2 YEAR CAGR
12.55%
5 YEAR CAGR
17.55%
10 YEAR CAGR